Bupivacaine-Liposomal Bupivacaine
Phase 2Small molecule
Bupivacaine-Liposomal Bupivacaine is one of 4 small molecule programs targeting Total Knee Replacement. It is currently in Phase 2.
1
Indications
2
Total Trials
2
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Total Knee Replacement
#DrugCompanyPhaseTrials
1Bupivacaine Liposome
Pacira Pharmaceuticals, IncPhase 3
Medrol
PfizerPreclinical
Bupivacaine-Liposomal Bupivacaine
YYale University
Phase 2
EVICEL
MMontefiore Medical Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- YYale University